EpiPen Underpriced Despite Times Complaints

"Outcry Over EpiPen Prices Hasn't Made Them Lower" is the misleading headline over Charles Duhigg's "Adventures in Capitalism" column in the New York Times business section. Mr. Duhigg writes, "I was surprised when my pharmacist informed me, months after those floggings and apologies had faded from the headlines, that I would still need to pay $609 for a box of two EpiPens."

"Outcry Over EpiPen Prices Hasn't Made Them Lower" is the misleading headline over Charles Duhigg's "Adventures in Capitalism" column in the New York Times business section. Mr. Duhigg writes, "I was surprised when my pharmacist informed me, months after those floggings and apologies had faded from the headlines, that I would still need to pay $609 for a box of two EpiPens."…